Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-890

Do I post 50 times a day repeating the same dribble over and over! 

You’ve made your point, I get your scepticism!

By now you can’t save the majority of holders who have stayed from 2 cents- 44 cents- 10 cents back to 21 cents!

At the very least you have to acknowledge the stability this stock is showing now is very encouraging?

You have to also acknowledge that presenting a a last minute poster abstract at a massive conference on Miami is extremely positive?

What about the announcement of a highly successful WHO director to little ole Biotron?

To me there’s too much happening here for this to this to end in nothing!

and can I ask your opinion on the below link, 8 patients and J & J jumped all over arrowheads hep B phase 2 results 

https://www.fiercebiotech.com/biotech/j-j-pays-175m-commits-to-1-6b-milestones-for-arrowhead-hepatitis-b-drug

surely this gives BiT just as much chance of a huge jv or takeover based on 27 patiients our hiv program treated